Suppression of inflammatory responses during myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis is regulated by AKT3 signaling

Vladislav Tsiperson, Ross C. Gruber, Michael F. Goldberg, Ayana Jordan, Jason G. Weinger, Fernando Macian-Juan, Bridget Shafit-Zagardo

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

AKT3, a member of the serine/threonine kinase AKT family, is involved in a variety of biologic processes. AKT3 is expressed in immune cells and is the major AKT isoform in the CNS representing 30% of the total AKTexpressed in spinal cord, and 50% in the brain. Myelin-oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (EAE) is a mouse model in which lymphocytes and monocytes enter the CNS, resulting in inflammation, demyelination, and axonal injury. We hypothesized that during EAE, deletion of AKT3 would negatively affect the CNS of AKT3-/- mice, making them more susceptible to CNS damage. During acute EAE, AKT3-/-mice were more severely affected than wild type (WT) mice. Evaluation of spinal cords showed that during acute and chronic disease, AKT3-/- spinal cords had more demyelination compared with WT spinal cords. Quantitative RT-PCR determined higher levels of IL-2, IL-17, and IFN-γ mRNA in spinal cords from AKT3-/- mice than WT. Experiments using bone marrow chimeras demonstrated that AKT3-/- mice receiving AKT3-deficient bone marrow cells had elevated clinical scores relative to control WT mice reconstituted with WT cells, indicating that altered function of both CNS cells and bone marrow-derived immune cells contributed to the phenotype. Immunohistochemical analysis revealed decreased numbers of Foxp3+ regulatory T cells in the spinal cord of AKT3-/- mice compared with WT mice, whereas in vitro suppression assays showed that AKT3-deficient Th cells were less susceptible to regulatory T cell-mediated suppression than their WT counterparts. These results indicate that AKT3 signaling contributes to the protection of mice against EAE.

Original languageEnglish (US)
Pages (from-to)1528-1539
Number of pages12
JournalJournal of Immunology
Volume190
Issue number4
DOIs
StatePublished - Feb 15 2013

Fingerprint

Myelin-Oligodendrocyte Glycoprotein
Autoimmune Experimental Encephalomyelitis
Spinal Cord
Demyelinating Diseases
Regulatory T-Lymphocytes
Bone Marrow Cells
Interleukin-17
Protein-Serine-Threonine Kinases
Acute Disease
Interleukin-2
Monocytes
Protein Isoforms
Chronic Disease
Bone Marrow

ASJC Scopus subject areas

  • Immunology

Cite this

Suppression of inflammatory responses during myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis is regulated by AKT3 signaling. / Tsiperson, Vladislav; Gruber, Ross C.; Goldberg, Michael F.; Jordan, Ayana; Weinger, Jason G.; Macian-Juan, Fernando; Shafit-Zagardo, Bridget.

In: Journal of Immunology, Vol. 190, No. 4, 15.02.2013, p. 1528-1539.

Research output: Contribution to journalArticle

@article{6b4921f207c14718ae4467415f482422,
title = "Suppression of inflammatory responses during myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis is regulated by AKT3 signaling",
abstract = "AKT3, a member of the serine/threonine kinase AKT family, is involved in a variety of biologic processes. AKT3 is expressed in immune cells and is the major AKT isoform in the CNS representing 30{\%} of the total AKTexpressed in spinal cord, and 50{\%} in the brain. Myelin-oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (EAE) is a mouse model in which lymphocytes and monocytes enter the CNS, resulting in inflammation, demyelination, and axonal injury. We hypothesized that during EAE, deletion of AKT3 would negatively affect the CNS of AKT3-/- mice, making them more susceptible to CNS damage. During acute EAE, AKT3-/-mice were more severely affected than wild type (WT) mice. Evaluation of spinal cords showed that during acute and chronic disease, AKT3-/- spinal cords had more demyelination compared with WT spinal cords. Quantitative RT-PCR determined higher levels of IL-2, IL-17, and IFN-γ mRNA in spinal cords from AKT3-/- mice than WT. Experiments using bone marrow chimeras demonstrated that AKT3-/- mice receiving AKT3-deficient bone marrow cells had elevated clinical scores relative to control WT mice reconstituted with WT cells, indicating that altered function of both CNS cells and bone marrow-derived immune cells contributed to the phenotype. Immunohistochemical analysis revealed decreased numbers of Foxp3+ regulatory T cells in the spinal cord of AKT3-/- mice compared with WT mice, whereas in vitro suppression assays showed that AKT3-deficient Th cells were less susceptible to regulatory T cell-mediated suppression than their WT counterparts. These results indicate that AKT3 signaling contributes to the protection of mice against EAE.",
author = "Vladislav Tsiperson and Gruber, {Ross C.} and Goldberg, {Michael F.} and Ayana Jordan and Weinger, {Jason G.} and Fernando Macian-Juan and Bridget Shafit-Zagardo",
year = "2013",
month = "2",
day = "15",
doi = "10.4049/jimmunol.1201387",
language = "English (US)",
volume = "190",
pages = "1528--1539",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "4",

}

TY - JOUR

T1 - Suppression of inflammatory responses during myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis is regulated by AKT3 signaling

AU - Tsiperson, Vladislav

AU - Gruber, Ross C.

AU - Goldberg, Michael F.

AU - Jordan, Ayana

AU - Weinger, Jason G.

AU - Macian-Juan, Fernando

AU - Shafit-Zagardo, Bridget

PY - 2013/2/15

Y1 - 2013/2/15

N2 - AKT3, a member of the serine/threonine kinase AKT family, is involved in a variety of biologic processes. AKT3 is expressed in immune cells and is the major AKT isoform in the CNS representing 30% of the total AKTexpressed in spinal cord, and 50% in the brain. Myelin-oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (EAE) is a mouse model in which lymphocytes and monocytes enter the CNS, resulting in inflammation, demyelination, and axonal injury. We hypothesized that during EAE, deletion of AKT3 would negatively affect the CNS of AKT3-/- mice, making them more susceptible to CNS damage. During acute EAE, AKT3-/-mice were more severely affected than wild type (WT) mice. Evaluation of spinal cords showed that during acute and chronic disease, AKT3-/- spinal cords had more demyelination compared with WT spinal cords. Quantitative RT-PCR determined higher levels of IL-2, IL-17, and IFN-γ mRNA in spinal cords from AKT3-/- mice than WT. Experiments using bone marrow chimeras demonstrated that AKT3-/- mice receiving AKT3-deficient bone marrow cells had elevated clinical scores relative to control WT mice reconstituted with WT cells, indicating that altered function of both CNS cells and bone marrow-derived immune cells contributed to the phenotype. Immunohistochemical analysis revealed decreased numbers of Foxp3+ regulatory T cells in the spinal cord of AKT3-/- mice compared with WT mice, whereas in vitro suppression assays showed that AKT3-deficient Th cells were less susceptible to regulatory T cell-mediated suppression than their WT counterparts. These results indicate that AKT3 signaling contributes to the protection of mice against EAE.

AB - AKT3, a member of the serine/threonine kinase AKT family, is involved in a variety of biologic processes. AKT3 is expressed in immune cells and is the major AKT isoform in the CNS representing 30% of the total AKTexpressed in spinal cord, and 50% in the brain. Myelin-oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (EAE) is a mouse model in which lymphocytes and monocytes enter the CNS, resulting in inflammation, demyelination, and axonal injury. We hypothesized that during EAE, deletion of AKT3 would negatively affect the CNS of AKT3-/- mice, making them more susceptible to CNS damage. During acute EAE, AKT3-/-mice were more severely affected than wild type (WT) mice. Evaluation of spinal cords showed that during acute and chronic disease, AKT3-/- spinal cords had more demyelination compared with WT spinal cords. Quantitative RT-PCR determined higher levels of IL-2, IL-17, and IFN-γ mRNA in spinal cords from AKT3-/- mice than WT. Experiments using bone marrow chimeras demonstrated that AKT3-/- mice receiving AKT3-deficient bone marrow cells had elevated clinical scores relative to control WT mice reconstituted with WT cells, indicating that altered function of both CNS cells and bone marrow-derived immune cells contributed to the phenotype. Immunohistochemical analysis revealed decreased numbers of Foxp3+ regulatory T cells in the spinal cord of AKT3-/- mice compared with WT mice, whereas in vitro suppression assays showed that AKT3-deficient Th cells were less susceptible to regulatory T cell-mediated suppression than their WT counterparts. These results indicate that AKT3 signaling contributes to the protection of mice against EAE.

UR - http://www.scopus.com/inward/record.url?scp=84873560332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873560332&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1201387

DO - 10.4049/jimmunol.1201387

M3 - Article

VL - 190

SP - 1528

EP - 1539

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 4

ER -